Medical Communications

Showing 15 posts of 6402 posts found.

sugar_tax

The UK sugar tax: A sweet or sour move?

May 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …
veeva_event

Speakers Announced for Veeva R&D Summit, Europe

May 3, 2018 Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

In the pharma industry, we tend to use a lot of acronyms. Even in every day life, we are shortening …
jeremy_hunt

450,000 missed breast cancer screenings, 270 lives potentially shortened

May 2, 2018 Medical Communications Jeremy Hunt, NHS, UK, biotech, drugs, pharma, pharmaceutical

An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s …
jon_neal-1_0

Takeda announces new UK MD, ahead of Shire transformation

May 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Takeda, appointment, pharma

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
ovariancancer

Ovarian cancer rates set to rise by 55%

May 1, 2018 Manufacturing and Production, Medical Communications biotech, drugs, ovarian cancer, pharma, pharmaceutical

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type …
gandhi

Lilly hires new leader of immuno-oncology

May 1, 2018 Manufacturing and Production, Medical Communications Eli Lilly, biotech, drugs, immunoconlogy, immunotherapy, pharma, pharmaceutical

Immuno-oncology has become a huge area of the oncology market, led by the wave of PD-1/L1 drugs that are reaping …
medopad

Connecting patients to doctors

April 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …
18538_700x200

Navigating CMC Requirements during drug development and post-approval

April 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia

This training will offer you the overview of the existing regulatory aspects of the CMC, and will also give you …
hans-bishop_2x

Juno CEO and Co-founder steps down in wake of Celgene acquisition

April 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Juno, appointment, pharma

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Sanofi, appointment, pharma

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …
lilly_entrance_web

Eli Lilly partners with Chinese institution to advance the nation’s diabetes and CVD care

April 27, 2018 Medical Communications, Research and Development China, Eli Lilly, cardiovascular disorders, cvd, diabetes, pharma, type 2 diabetes

EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …

Two FDA drug review Directors to leave the agency, with no permanent replacements in place

April 27, 2018 Medical Communications, Sales and Marketing FDA, pharma

The FDA has revealed that two of its prominent Directors are set to retire from the agency, leaving three of …
alexion_sign

Investigational Alexion drug proves non-inferior to Soliris in rare blood disease

April 27, 2018 Medical Communications, Research and Development Alexion, paroxysmal nocturnal haemoglobinuria, pharma, soliris

Alexion has lifted the curtain on new data for its C5 complement inhibitor ALXN1210, demonstrating its non-inferiority to another of …
fda2outsideweb

FDA moots a return look at Acadia’s lead drug

April 27, 2018 Medical Communications, Sales and Marketing Acacia, FDA, nuplazid, pharma

Following a non-profit report that higher rates of death were associated with Acadia Pharmaceuticals’ Nuplazid, Scott Gottlieb has made comments …
The Gateway to Local Adoption Series

Latest content